Get started
Author

Cori A. Malinky

Observed names: C. Malinky, Cori Malinky
ORCID: 0000-0003-1828-6759
Observed ORCID: 0000-0003-1828-6759
OpenAlex ID: A5068215825
Differing activities of oxysterol-binding protein (OSBP) targeting anti-viral compounds
2019 · Brett L. Roberts, Zachary C. Severance, et al. · Antiviral Research · 53
PDF
Structure–Activity Relationships of Ligand Binding to Oxysterol-Binding Protein (OSBP) and OSBP-Related Protein 4
2023 · Zachary C. Severance, Juan I. Nuñez, et al. · Journal of Medicinal Chemistry · 11
PDF
DARK Classics in Chemical Neuroscience: Loperamide
2021 · Cori A. Malinky, Craig W. Lindsley, et al. · ACS Chemical Neuroscience · 9
Brain-Penetrant Macrocycles: Design Considerations, Future Prospects, and Call for Papers
2024 · Cori A. Malinky, Aaron M. Bender · Journal of Medicinal Chemistry · 4
Abstract 5623: Identification of CGT4255 an EGFR sparing, pan-mutant HER2 clinical development candidate with potential best-in-class brain penetration
2025 · Mark J. Chicarelli, Tanna Bettendorf, et al. · Cancer Research · 1
Abstract 410: Characterization of CGT1263, a KRAS (ON/OFF) inhibitor clinical candidate with selectivity for mutant KRAS over HRAS and NRAS.
2026 · John Fischer, Kim Alley, et al. · Cancer Research
Abstract 5869: Preclinical characterization of CGT4255, an EGFR sparing, pan-mutant HER2 clinical development candidate with potential best-in-class brain penetration
2026 · Paul Larsen, Tanna Bettendorf, et al. · Cancer Research
Preclinical characterization of a novel, wild-type-sparing, JAK2 V617F mutant-selective inhibitor
2025 · Mark Chicarelli, Michelle Crow, et al. · Blood
PDF
Abstract B024: Identification of a potent KRAS (ON) inhibitor clinical candidate series with selectivity for mutant KRAS over HRAS and NRAS
2025 · John Fischer, Kim Alley, et al. · Molecular Cancer Therapeutics
Abstract P4-12-16: Identification of CGT4255 an EGFR sparing, ErbB2 clinical development candidate with activity across activating mutations in systemic and CNS tumors
2025 · Mark J. Chicarelli, Tanna Bettendorf, et al. · Clinical Cancer Research
Abstract 6974: Identification of a potent KRAS (ON) inhibitor with selectivity for mutant KRAS over HRAS and NRAS
2025 · Keith Koch, Kim Alley, et al. · Cancer Research
120 (PB108): Identification of a Potent KRAS Dual On/Off Inhibitor with Selectivity for Mutant KRAS over HRAS and NRAS
2024 · J. Fischer, K. Alley, et al. · European Journal of Cancer
Abstract PO3-26-02: Identification of a novel, brain penetrant, EGFR sparing, ErbB2 inhibitor with activity against oncogenic ErbB2 mutations
2024 · Mark J. Chicarelli, Ben Arwood-Levine, et al. · Cancer Research
Abstract 4486: Characterization of a novel mutant selective, EGFR sparing, ErbB2 inhibitor with activity across activating mutations in systemic and CNS tumors
2024 · Jennifer Fulton, Tanna Bettendorf, et al. · Cancer Research
Works count: 14
Citation count: 78
H-index: 4
I10-index: 2
Year
Topic
Type